+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Continuous Renal Replacement Therapy Market by Product, Modality, Age Group, Indication, End User - Forecast 2024-2030

  • PDF Icon

    Report

  • 190 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5896406
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Continuous Renal Replacement Therapy Market size was estimated at USD 14.28 billion in 2023, USD 15.49 billion in 2024, and is expected to grow at a CAGR of 8.55% to reach USD 25.37 billion by 2030.

Continuous renal replacement therapy (CRRT) is a specialized medical treatment utilized for continuous dialysis to allow solute and fluid homeostasis. CRRT provides continuous renal support by mimicking the natural function of the kidneys in removing waste products, excess fluids, and electrolytes from the blood while maintaining optimal acid-base balance. The CRRT is witnessing significant growth due to several factors, including the increasing prevalence of AKI incidences globally and rising technological advancements in extracorporeal dialysis and lithotripsy. In addition, significant advantages of CRRT in intermittent blood purification boost the market expansion.

However, the high cost associated with the renal replacement procedure and concerns over potential complications during therapies subsequently hampers the growth of CRRT. Moreover, ongoing innovation and research activities, including developing novel membrane materials and advanced therapy options with improved biocompatibility and widening uses of CCRT systems for pediatric patients, contribute to the future CRRT.

Regional Insights

In the Americas, countries such as the United States and Canada hold a significant share of the CRRT market, with the major factors driving the growth, including the increasing prevalence of renal diseases and technological advancements and research & development activities by major companies. Additionally, in Europe, the presence of leading manufacturers, increased need for advanced therapies, and supportive government policies, such as European CE marking for renal therapy products, contribute to the expansion of the CRRT market.

On the other hand, the Middle East and Africa region has witnessed a growth in need for CRRT solutions due to rising awareness about renal diseases and continuously developing healthcare infrastructure adopting new treatment options supported by clinical studies. In Asia-Pacific, China, Japan, and India are major contributors to the CRRT market growth due to factors including a large patient pool with kidney disorders, a growing medical tourism industry, and expanding healthcare infrastructure, coupled with an increasing focus on research initiatives enabling rapid adoption of advanced technologies in this region. As a result, manufacturers remain agile by adapting regulatory compliance measures and participating in strategic collaborations with governments and entities to form footprints in the CRRT market.

Market Trends by Segment

  • Product: Growing prevalence toward acute kidney injury (AKI) boosting a need for CRRT devices for seamless treatment procedures
  • Modality: Utilization of continuous venovenous hemodiafiltration for liberal fluid management in renal therapies
  • Age Group: Differing CRRT requirements among pediatric population
  • Indication: Growing adoption of non-renal indications in extracorporeal renal therapies
  • End User: Increasing uses of CRRT devices in hospitals to cater a patients need

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

B. Braun Receives FDA Clearance for AQUAbase nX Reverse Osmosis System

B. Braun Medical Inc. has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its AQUAbase nX Reverse Osmosis System. This innovative device offers dialysis patients access to high-quality water without the use of chemicals, boasting an impressive raw water conversion rate of up to 75%.

Quanta Receives FDA 510(k) Clearance for Expanded Indication of Continuous Renal Replacement Therapies

Quanta Dialysis Technologies, a medical technology company, has announced that its Quanta Dialysis System has received FDA 510(k) approval for an expanded indication. This compact and user-friendly hemodialysis device now offers Continuous Renal Replacement Therapy (CRRT), including Continuous VenoVenous Hemodialysis (CVVHD) and Slow Continuous Ultrafiltration (SCUF). The Quanta Dialysis System stands out as the only dialysis device cleared by the FDA to provide Intermittent Hemodialysis (IHD), Sustained Low-Efficiency Dialysis (SLED), and Bagless CRRT.

Rockwell Medical Announces 3-Year Co-Promotional Collaboration with B. Braun Medical

Rockwell Medical, Inc., a healthcare company, has entered into a 3-year co-promotion services agreement with B. Braun Medical Inc. As part of the agreement, B. Braun is planned to be compensated for any sales resulting from its promotional efforts. This strategic partnership allows Rockwell Medical to expand its customer base and generate new business leads, ultimately improving the lives of more hemodialysis patients.

Key Company Profiles

The report delves into recent significant developments in the Continuous Renal Replacement Therapy Market, highlighting leading vendors and their innovative profiles. These include Anjue Medical Equipment Co., Ltd., Asahi Kasei Medical Co., Ltd., B. Braun SE, Baxter International Inc., Biomedica Medizinprodukte GmbH, Braun & Co. Limited, CytoSorbents Corporation, DIAMED Medizintechnik GmbH, Fresenius Medical Care AG & Co. KGaA, Infomed SA, Joline GmbH & Co. KG, Medites Pharma spol. s.r.o, Medtronic PLC, Miromatrix Medical Inc., Nextkidney B.V., Nikkiso Co., Ltd., Ningbo Tianyi Medical Devices Co., Ltd., Nipro Corporation, Nuwellis, Inc., Quanta Dialysis Technologies Limited, SB-KAWASUMI LABORATORIES, INC., Shionogi & Company, Limited, Sphingotec GmbH, SWS Hemodialysis Care Co. Ltd., Thermo Fisher Scientific Inc., and Toray Medical Co., Ltd. by Toray Industries, Inc.

This research report offers invaluable insights into various crucial aspects of the Continuous Renal Replacement Therapy Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidences of acute kidney injury (AKI) and chronic kidney diseases (CKD)
5.1.1.2. Availability of improved CCRT systems for pediatric and neonatal patients
5.1.2. Restraints
5.1.2.1. High cost of continuous renal replacement therapy procedure
5.1.3. Opportunities
5.1.3.1. Ongoing research and development for enhanced safety and efficacy of CRRT
5.1.3.2. Favorable government approvals for CRRT machines and techniques
5.1.4. Challenges
5.1.4.1. Technical complications associated with continuous renal replacement therapy
5.2. Market Segmentation Analysis
5.2.1. Product: Growing prevalence toward acute kidney injury (AKI) boosting a need for CRRT devices for seamless treatment procedures
5.2.2. Modality: Utilization of continuous venovenous hemodiafiltration for liberal fluid management in renal therapies
5.2.3. Age Group: Differing CRRT requirements among pediatric population
5.2.4. Indication: Growing adoption of non-renal indications in extracorporeal renal therapies
5.2.5. End User: Increasing uses of CRRT devices in hospitals to cater a patients need
5.3. Market Trend Analysis
5.3.1. Established companies in the North America receiving favorable government approvals for CRRT and their potential expansion in the South American market
5.3.2. Growing number of renal patients in Asia leads to an increased need for continuous renal replacement therapies
5.3.3. Supportive government policies and financial initiatives from established vendors for the kidney health contributed to CRRT advancement across EMEA
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework Analysis
6. Continuous Renal Replacement Therapy Market, by Product
6.1. Introduction
6.2. CRRT Systems
6.3. Dialysates & Replacement Fluids
6.4. Disposables
7. Continuous Renal Replacement Therapy Market, by Modality
7.1. Introduction
7.2. Continuous Venovenous Hemodiafiltration
7.3. Continuous Venovenous Hemodialysis
7.4. Continuous Venovenous Hemofiltration
7.5. Slow Continuous Ultrafiltration
8. Continuous Renal Replacement Therapy Market, by Age Group
8.1. Introduction
8.2. Adults
8.3. Pediatrics
9. Continuous Renal Replacement Therapy Market, by Indication
9.1. Introduction
9.2. Non-renal
9.3. Renal
10. Continuous Renal Replacement Therapy Market, by End User
10.1. Introduction
10.2. Dialysis Clinics
10.3. Homecare
10.4. Hospitals
11. Americas Continuous Renal Replacement Therapy Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Continuous Renal Replacement Therapy Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Continuous Renal Replacement Therapy Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. B. Braun Receives FDA Clearance for AQUAbase nX Reverse Osmosis System
14.3.2. Quanta Receives FDA 510(k) Clearance for Expanded Indication of Continuous Renal Replacement Therapies
14.3.3. Rockwell Medical Announces 3-Year Co-Promotional Collaboration with B. Braun Medical
14.3.4. Nuwellis, DaVita partner on ultrafiltration therapy pilot program
14.3.5. Baxter, Miromatrix Partner on Liver Failure Research
14.3.6. PBMC Launches New Renal Therapy Option for Dialysis Patients
14.3.7. SeaStar Medical, Nuwellis Partner on Kidney Injury Treatment
14.3.8. Spectral Medical Announces Strategic Joint Venture with Infomed to Accelerate Commercialization of DIMI and SAMI Dialysis Devices.
14.3.9. Baxter Announces U.S. FDA Clearance of ST Set Used to Help Treat Acute Kidney Injury Patients in the Hospital
15. Competitive Portfolio
15.1. Key Company Profiles
15.2. Key Product Portfolio
List of Figures
FIGURE 1. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET RESEARCH PROCESS
FIGURE 2. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET DYNAMICS
FIGURE 7. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2023 VS 2030 (%)
FIGURE 10. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
FIGURE 12. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 14. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 16. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 26. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CRRT SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CRRT SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DIALYSATES & REPLACEMENT FLUIDS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DIALYSATES & REPLACEMENT FLUIDS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY BODYLINE SETS & TUBES, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY BODYLINE SETS & TUBES, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HEMOFILTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HEMOFILTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIAFILTRATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIAFILTRATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIALYSIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIALYSIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMOFILTRATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMOFILTRATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY SLOW CONTINUOUS ULTRAFILTRATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY SLOW CONTINUOUS ULTRAFILTRATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ADULTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ADULTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PEDIATRICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY NON-RENAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY NON-RENAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY RENAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY RENAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DIALYSIS CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DIALYSIS CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOMECARE, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOMECARE, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 52. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 53. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
TABLE 54. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
TABLE 55. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
TABLE 56. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
TABLE 57. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 58. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 59. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 60. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 61. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 62. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 63. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 64. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 65. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 66. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 67. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
TABLE 68. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
TABLE 69. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
TABLE 70. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
TABLE 71. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 72. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 73. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 74. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 75. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 76. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 77. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 78. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 79. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
TABLE 80. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
TABLE 81. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
TABLE 82. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
TABLE 83. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 84. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 85. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 86. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 87. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 88. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 89. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 90. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 91. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
TABLE 92. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
TABLE 93. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
TABLE 94. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
TABLE 95. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 96. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 97. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 98. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 99. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 100. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 101. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 102. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 103. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
TABLE 104. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
TABLE 105. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
TABLE 106. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
TABLE 107. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 108. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 109. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 110. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 111. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 112. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 113. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 114. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 115. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
TABLE 116. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
TABLE 117. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
TABLE 118. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
TABLE 119. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 120. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 121. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 122. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 123. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 124. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 125. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 126. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 127. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 128. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 129. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
TABLE 130. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
TABLE 131. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
TABLE 132. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
TABLE 133. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 134. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 135. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 136. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 137. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 138. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 140. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 141. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 142. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 143. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
TABLE 144. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
TABLE 145. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
TABLE 146. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
TABLE 147. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 148. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 149. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 150. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 151. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 152. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 153. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 154. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 155. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
TABLE 156. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
TABLE 157. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
TABLE 158. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
TABLE 159. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 160. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 161. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 162. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 163. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 164. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 165. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 166. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 167. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
TABLE 168. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
TABLE 169. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
TABLE 170. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
TABLE 171. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 172. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 173. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 174. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 175. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 176. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 177. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 178. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 179. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
TABLE 180. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
TABLE 181. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
TABLE 182. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
TABLE 183. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 184. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 185. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 186. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 187. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 188. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 189. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 190. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 191. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
TABLE 192. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
TABLE 193. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
TABLE 194. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
TABLE 195. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 196. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 197. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 198. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 199. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 200. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 201. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 202. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 203. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
TABLE 204. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
TABLE 205. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
TABLE 206. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
TABLE 207. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 208. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 209. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 210. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 211. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 212. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 213. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 214. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 215. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
TABLE 216. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
TABLE 217. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
TABLE 218. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
TABLE 219. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 220. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 221. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 222. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 223. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 224. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 225. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 226. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 227. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
TABLE 228. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
TABLE 229. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
TABLE 230. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
TABLE 231. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 232. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 233. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 234. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 235. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 236. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 237. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 238. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 239. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
TABLE 240. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
TABLE 241. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
TABLE 242. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
TABLE 243. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 244. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 245. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 246. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 247. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 248. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 249. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 250. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 251. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
TABLE 252. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
TABLE 253. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
TABLE 254. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
TABLE 255. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 256. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 257. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 258. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 259. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 260. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 261. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 262. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 263. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
TABLE 264. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
TABLE 265. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
TABLE 266. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
TABLE 267. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 268. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 269. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 270. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 271. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 272. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 273. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 274. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 275. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
TABLE 276. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
TABLE 277. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
TABLE 278. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
TABLE 279. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 280. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 281. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 282. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 283. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 284. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 299

Companies Mentioned

  • Anjue Medical Equipment Co., Ltd.
  • Asahi Kasei Medical Co., Ltd.
  • B. Braun SE
  • Baxter International Inc.
  • Biomedica Medizinprodukte GmbH
  • Braun & Co. Limited
  • CytoSorbents Corporation
  • DIAMED Medizintechnik GmbH
  • Fresenius Medical Care AG & Co. KGaA
  • Infomed SA
  • Joline GmbH & Co. KG
  • Medites Pharma spol. s.r.o
  • Medtronic PLC
  • Miromatrix Medical Inc.
  • Nextkidney B.V.
  • Nikkiso Co., Ltd.
  • Ningbo Tianyi Medical Devices Co., Ltd.
  • Nipro Corporation
  • Nuwellis, Inc.
  • Quanta Dialysis Technologies Limited
  • SB-KAWASUMI LABORATORIES, INC.
  • Shionogi & Company, Limited
  • Sphingotec GmbH
  • SWS Hemodialysis Care Co. Ltd.
  • Thermo Fisher Scientific Inc.
  • Toray Medical Co., Ltd. by Toray Industries, Inc.

Methodology

Loading
LOADING...

Table Information